The World Health Organization (WHO) provides guidelines, recommendations and key considerations to support differentiated care across the HIV care continuum. The 2016 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommend a differentiated care approach to address the diverse needs of people living with HIV.
Since the 2016 WHO consolidated ARV guidelines were developed, appreciation has been growing that different types of clients may also benefit from models of care specifically for clinically stable clients. The 2017 Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations outlines the rationale for and features of differentiated ART delivery for clinically stable clients in these populations. The document complements A Decision Framework for differentiated antiretroviral therapy delivery for children, adolescents and pregnant and breastfeeding women (see above, Decision Frameworks).
The 2017 Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy also include differentiated care, or differentiated service delivery. This guideline adds recommendations for appropriate packages of care for clients presenting or returning to care with either advanced HIV disease or when clinically well.
In July 2017, WHO prequalified the first HIV self-test. WHO has recommended HIV self-testing since November 2016 when they released a supplement guideline on HIV self-testing and partner notification. This supplement was to the 2015 Consolidated guidelines on HIV testing services.
WHO also has Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations and Consolidated guidelines on person-centred HIV patient monitoring and case surveillance.